bioMérieux: launches Biofire Mycoplasma
(CercleFinance.com) - bioMérieux announces the launch of Biofire Mycoplasma, an innovative test for the detection of mycoplasma in biopharmaceuticals (antibodies, hormones, cell or gene therapies, etc.
), the most dynamic segment of the pharmaceutical industry.
With this test, the extraction, amplification and detection of bacterial DNA are completely automated and can be performed outside the laboratory by anyone who has had just very basic training.
"The new Biofire Mycoplasma test, which is available in the United States, will be launched in some countries in Europe and the Asia-Pacific region in the coming months," the in vitro diagnostics specialist said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
), the most dynamic segment of the pharmaceutical industry.
With this test, the extraction, amplification and detection of bacterial DNA are completely automated and can be performed outside the laboratory by anyone who has had just very basic training.
"The new Biofire Mycoplasma test, which is available in the United States, will be launched in some countries in Europe and the Asia-Pacific region in the coming months," the in vitro diagnostics specialist said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.